A key part of the project will be a randomised, controlled trial across European countries led by ESCAPE project partner Professor Christoph Herrmann-Lingen, Universitätsmedizin Göttingen (Germany).
Focusing on patients with chronic heart failure, psychological distress and at least two other physical co-morbidities, the trial will compare the outcomes of ESCAPE’s new, blended collaborative care approach with current patient care. Researchers will determine which approach leads to the best health-related quality of life for patients.
Thanks to the hard work of the consortium, ESCAPE’s clinical trial has officially begun at the Göttingen site! The first patient was enrolled on April 1st and randomisation of patients began on July 12th. We are all eager to assess the ESCAPE approach over the coming months.